Tumor > Neotect

Scott Williams
Apr 2, 2002

Neotect (Tc99-m-Depreotide) (P-829)

Clinical

Chemistry and pharmacology

Patient Instructions

Imaging Protocol

Interpretation

Indications for the exam

Dosimetry

Complications/Side Effects

HAMA Formation (Immunogenicity)



Latest in Nuclear Medicine
Scientist in lab coat holding glowing atomic symbol representing scientific innovation and research
Radnostix to sell nuclear fuel processing assets for $13.5M
October 1, 2026
Eden logo with blue orbital symbol and dark text wordmark
Eden selects Kiewit as partner for NM isotope facility
September 28, 2026
Explore Innovations at EANM 2026
Sponsored
Explore Innovations at EANM 2026
October 1, 2026
Blue approved stamp seal with distressed circular border and diagonal banner
Curium gets FDA approval for Lu-177 injection for GEP-NETs
September 15, 2026
Related Stories
Whole Body
Nuclear Medicine
Prostascint (111In-Capromab Pendetide) (CYT-356)
Primary Ct
Nuclear Medicine
PET > PET tumor imaging > Breast Cancer
Lsegs
Nuclear Medicine
Pulmonary
Explore Innovations at EANM 2026
Sponsor Content
Explore Innovations at EANM 2026
More in Nuclear Medicine
Radnostix to sell nuclear fuel processing assets for $13.5M
By AuntMinnie.com staff writers
Assets include a U.S. Nuclear Regulatory Commission (NRC) license, patented technology, and related technical materials.
October 1, 2026
Scientist in lab coat holding glowing atomic symbol representing scientific innovation and research
Eden selects Kiewit as partner for NM isotope facility
By AuntMinnie.com staff writers
The project is expected to create 205 jobs and generate more than $1.5 billion in economic impact over 10 years.
September 28, 2026
Eden logo with blue orbital symbol and dark text wordmark
Telix inks deal to acquire ITM for $1.65B
By Erik L. Ridley
The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.
September 21, 2026
Glowing atomic nucleus symbol with orbiting electrons in a modern laboratory setting with industrial equipment
Curium gets FDA approval for Lu-177 injection for GEP-NETs
By AuntMinnie.com staff writers
The radioligand therapy delivers targeted radiation to GEP-NETs by binding to somatostatin receptors expressed on these tumors.
September 15, 2026
Blue approved stamp seal with distressed circular border and diagonal banner
Ionetix begins shipping At-211 in North America
By AuntMinnie.com staff writers
Alpha emitters like At-211 deliver high-energy radiation over a very short range.
September 2, 2026
Hand holding glowing atom symbol with orbital rings on blue technology background
IU Health launches theranostics center
By AuntMinnie.com staff writers
The center is supported by a $40 million commitment.
August 19, 2026
Hand presenting glowing atom model with orbital rings in blue and gold light against blurred background
Radnostix reports revenue decline in Q2
By AuntMinnie.com staff writers
The company attributed the revenue dip to two voluntary product recalls and the Cobalt-60 hot-cell shutdown.
August 13, 2026
Overlapping U.S. dollar bills showing Benjamin Franklin portrait and Federal Reserve seal
ITM receives Complete Response Letter for ITM-11
By AuntMinnie.com staff writers
The FDA stated that it's unable to approve the NDA in its present form.
August 10, 2026
Hand holding glowing atomic nucleus symbol with orbiting electrons against blue technology background
Plus Therapeutics rebrands as Cerenome
By AuntMinnie.com staff writers
The move reflects the company's evolution from a therapeutics-focused organization into an integrated central nervous system (CNS) oncology company.
August 3, 2026
Plus Therapeutics and Ceremone company logos featuring geometric symbols and branded text
Novartis secures expanded approval for Pluvicto
By AuntMinnie.com staff writers
Pluvicto can now be used as therapy in patients with PSMA-positive metastatic hormone-sensitive prostate cancer, in combination with an androgen receptor pathway inhibitor.
July 31, 2026
X-ray of pelvis showing inflamed prostate gland highlighted in red
SNMMI issues analysis of 2027 HOPPS proposed rule
By AuntMinnie.com staff writers
The proposed rule includes several positive code-level changes for nuclear medicine providers.
July 29, 2026
SNM MIT red and white geometric block logo
ITM launches new oncology therapeutics division
By AuntMinnie.com staff writers
Lumara Bio will focus resources toward commercial readiness for ITM's lead drug candidate, lutetium-177 (Lu-177) edotreotide (ITM-11).
July 27, 2026
Lumara Bio logo with abstract sunburst symbol, a division of ITM
Page 1 of 445
Next Page